Keith M Sullivan

Keith M Sullivan

UNVERIFIED PROFILE

Are you Keith M Sullivan?   Register this Author

Register author
Keith M Sullivan

Keith M Sullivan

Publications by authors named "Keith M Sullivan"

Are you Keith M Sullivan?   Register this Author

61Publications

1308Reads

48Profile Views

Application of stem cell transplantation in autoimmune diseases.

Curr Opin Hematol 2019 Nov;26(6):392-398

Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOH.0000000000000531DOI Listing
November 2019

Allogeneic HSCT for autoimmune disease: a shared decision.

Nat Rev Rheumatol 2019 Sep 17. Epub 2019 Sep 17.

Duke University Medical Center, Durham, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41584-019-0306-7DOI Listing
September 2019

How I treat refractory chronic graft-versus-host disease.

Blood 2019 Mar 23;133(11):1191-1200. Epub 2019 Jan 23.

Division of Hematological Malignancies and Cellular Therapy, Department of Medicine.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2018-04-785899DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6418480PMC
March 2019

Use of the National Institutes of Health Consensus Guidelines Improves the Diagnostic Sensitivity of Gastrointestinal Graft-Versus-Host Disease.

Arch Pathol Lab Med 2018 09 26;142(9):1098-1105. Epub 2018 Apr 26.

From the Departments of Pathology (Drs Cardona, Detweiler, Shealy, and Howell) and Internal Medicine (Drs Sung, Wild, Poleski, Balmadrid, and Sullivan), Duke University Medical Center, Durham, North Carolina; and the Department of Biostatistics (Ms Cirrincione), Duke Cancer Institute, Durham, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2017-0054-OADOI Listing
September 2018

Shared Decision-Making in Hematopoietic Stem Cell Transplantation for Sickle Cell Disease.

Biol Blood Marrow Transplant 2018 05 9;24(5):883-884. Epub 2018 Apr 9.

Adult Sickle Cell Center, Duke University Medical Center, Durham, North Carolina; Division of Hematology, Duke University Medical Center, Durham, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2018.04.001DOI Listing
May 2018

Autologous Stem-Cell Transplantation for Severe Scleroderma.

N Engl J Med 2018 03;378(11):1066-1067

University of California, Los Angeles, Los Angeles, CA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1801275DOI Listing
March 2018

Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma.

N Engl J Med 2018 01;378(1):35-47

From the Duke University Medical Center (K.M.S., O.C., E.W.S.C.) and RTI International (D.W.), Durham, and Rho Federal Systems Division, Chapel Hill (L.K.-E., A.P., B.E., S.C.) - all in North Carolina; National Institute of Allergy and Infectious Diseases, Bethesda, MD (E.A.G., B.W., L.M.G., J.S.G.); Colorado Blood Cancer Institute, Denver (P.A.M., R.A.N.); University of Texas McGovern Medical School (M.D.M.) and M.D. Anderson Cancer Center (C.H.) - both in Houston; Vanderbilt University, Nashville (L.J.C., K.P.); University of Michigan, Ann Arbor (D.K., J.R.S.); Case Western Reserve University and University Hospitals, Cleveland (R.J.F.); University of Alabama, Birmingham (S.M.); Boston University, Boston (R.W.S.); University of Virginia, Charlottesville (K.B.); University of Washington (M.H.W., D.E.F.) and the Fred Hutchinson Cancer Research Center (G.E.G., S.H.) - both in Seattle; University of California, Los Angeles, Los Angeles (J.G., S.K., D.E.F.); City of Hope National Medical Center, Duarte, CA (S.F.); Medical University of South Carolina, Charleston (R.M.S.); Mayo Clinic, Scottsdale, AZ (L.G.); University of Calgary, Calgary, AB, Canada (J.S., S.L.); Washington University, St. Louis (R.B.); Medical College of Wisconsin, Milwaukee (M.E.C., C.K.-T.); Ottawa Hospital Research Institute, Ottawa (C.B.); University of Pittsburgh, Pittsburgh (T.M., R.T.D.); and University of Toledo Medical Center, Toledo, OH (M.B.K.).

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5846574PMC
http://dx.doi.org/10.1056/nejmoa1703327DOI Listing
January 2018

Manufacture of Autologous CD34 Selected Grafts in the NIAID-Sponsored HALT-MS and SCOT Multicenter Clinical Trials for Autoimmune Diseases.

Biol Blood Marrow Transplant 2017 Sep 30;23(9):1463-1472. Epub 2017 Jun 30.

Division of Allergy, Immunology and Transplantation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.05.018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5761325PMC
September 2017

Indications and Results of HLA-Identical Sibling Hematopoietic Cell Transplantation for Sickle Cell Disease.

Biol Blood Marrow Transplant 2016 Feb 21;22(2):207-211. Epub 2015 Oct 21.

Fred Hutchinson Cancer Research Center and the University of Washington School of Medicine, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2015.10.017DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5031360PMC
February 2016

Reduced-intensity allogeneic transplantation using alemtuzumab from HLA-matched related, unrelated, or haploidentical related donors for patients with hematologic malignancies.

Biol Blood Marrow Transplant 2014 Feb 20;20(2):257-63. Epub 2013 Nov 20.

Adult Stem Cell Transplant Program, Division of Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2013.11.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4140655PMC
February 2014

Adult dual umbilical cord blood transplantation using myeloablative total body irradiation (1350 cGy) and fludarabine conditioning.

Biol Blood Marrow Transplant 2011 Jun 22;17(6):867-74. Epub 2010 Sep 22.

Adult Stem Cell Transplant Program, Division of Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, NC 27705, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2010.09.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3877679PMC
June 2011

Stem-cell transplantation for sickle cell disease.

N Engl J Med 2010 Mar;362(10):955-6; author reply 956

View Article

Download full-text PDF

Source
March 2010

Hematopoietic cell transplantation for autoimmune disease: updates from Europe and the United States.

Biol Blood Marrow Transplant 2010 Jan 4;16(1 Suppl):S48-56. Epub 2009 Nov 4.

Division of Cellular Therapy, Duke University Medical Center, Durham, North Carolina 27708, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2009.10.034DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3448948PMC
January 2010

Carbon monoxide diffusion capacity: how low can you go for hematopoietic cell transplantation eligibility?

Biol Blood Marrow Transplant 2009 Apr;15(4):447-53

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2008.12.509DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2676410PMC
April 2009

Cyclophosphamide in scleroderma lung disease.

N Engl J Med 2006 Sep;355(11):1173-4; author reply 1174

View Article

Download full-text PDF

Source
September 2006

Chronic graft-versus-host disease.

Blood Rev 2006 Jan 7;20(1):15-27. Epub 2005 Apr 7.

Division of Cellular Therapy, Duke University Medical Center, 2400 Pratt Street DUMC 3961, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.blre.2005.01.007DOI Listing
January 2006

Adult recipients of umbilical cord blood transplants after nonmyeloablative preparative regimens.

Biol Blood Marrow Transplant 2004 Aug;10(8):569-75

Division of Cellular Therapy/BMT, Duke University Medical Center, Durham, North Carolina 27710, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S108387910400244
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2004.05.001DOI Listing
August 2004

Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and beta-thalassemia.

Biol Blood Marrow Transplant 2003 Aug;9(8):519-28

Department of Pediatrics, Johns Hopkins Hospital and Oncology Center, Baltimore, Maryland, USA.

View Article

Download full-text PDF

Source
August 2003

Morbidity and mortality of chronic GVHD after hematopoietic stem cell transplantation from HLA-identical siblings for patients with aplastic or refractory anemias.

Biol Blood Marrow Transplant 2002 ;8(1):47-56

Fred Hutchinson Cancer Research Center and the University of Washington, Seattle 98109-1024, USA.

View Article

Download full-text PDF

Source
July 2003

Bone marrow transplantation for non-malignant disease.

Authors:
Keith M Sullivan

Int J Hematol 2002 Aug;76 Suppl 1:169-70

Division of Medical Oncology and Transplantation, Duke University Medical Center, Durham, NC, USA.

View Article

Download full-text PDF

Source
August 2002

Late Effects of Hematopoietic Stem Cell Transplantation; Bone Marrow Transplantation.

Hematology 2000 ;5(3):209-222

Institute of Oncology, Hacettepe University, Faculty of Medicine, Ankara-Turkey.

View Article

Download full-text PDF

Source
January 2000

Bone Marrow Transplantation for Non-Malignant Disease.

Hematology Am Soc Hematol Educ Program 2000 :319-338

View Article

Download full-text PDF

Source
January 2000